Phase 1 N=12 Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida
Candida Infection · Premature Infant
Primary: Stool Fungal Burden — 500; 55000; 1671; 622.5 cfu per gram — p=0.9
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=66 Balanced Lifestyle for Undergraduate Excellence - Mobile (Project BLUEM)
Binge Drinking · Alcohol Drinking in College · Behavior, Drinking
Primary: Daily Drinking Questionnaire — 7.43; 8.11 drinks per week — p=<0.05
N/A N=65 Multi-Center Pivotal Study of Radiofrequency Device
Body Fat
Primary: % of Photos Identified Correctly When Comparing 12 Week Follow Up to Baseline — 57 % of photos identified correctly
Phase 3 N=618 A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
Crohn's Disease
Primary: US Specific: Percentage of Participants With Crohn's Disease Activity Index (CDAI) Clinical Remission — 19.8; 42.0; 40.3 percentage of participants — p=<0.001
N/A N=458 Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology
Atrial Fibrillation
Primary: Number of Participants With a Safety Event — 2; 0 Participants
N/A N=75 Prospective Trial Comparing Two Different Polypropylene Meshes for Inguinal Hernias
Hernia, Inguinal
Primary: Inguinal Hernia Mesh Insertion Times — 9.76; 8.70 Minutes — p=0.523
N/A N=60 A Survey on Efficacy and Safety in Patients With Endometriosis
Endometriosis
Primary: Change in the Volume of Ovarian Chocolate Cyst (If There Are Two or More Cysts, a Total Volume) — 26; 13; 13 Participants — p==0.0533
Phase 2 N=39 Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis
Chronic Kidney Disease Requiring Chronic Dialysis
Primary: Percentage of Participants Who Have a Defined Increase in 24-hour Urine Volume From Baseline to Week 5 — 33 percentage of participants
Phase 2 N=12 A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)
Chronic Myeloid Leukemia (CML) · Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Primary: Phase 1: Number of Participants With Dose-limiting Toxicities (DLTs) as a Measure of Safety Profile to Determine Recommended Dose of Ponatinib — 0; 0; 1; 1 Participants
N/A N=33 Validation of an iPhone-based Event Recorder for Arrhythmia Detection
Arrhythmia, Palpitations, Lightheadedness
Primary: Validation of an iPhone-based Event Recorder for Arrhythmia Detection — 14; 12; 8; 8 participants
N/A N=579 Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
Exocrine Pancreatic Insufficiency · Pancreatic Diseases · Digestive System Diseases
Primary: Number of Patients With Adverse Drug Reaction — 36 participants
N/A N=150 Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity
Gynecologic Cancer · Colorectal Cancer · Lung Cancer
Primary: Difference in Health Insurance Knowledge Between Historical Control Arm and I Can PIC Arm — 72.45; 77.02 score on a scale — p=0.15
Phase 4 N=59 Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis
Rabies
Primary: Protective Humoral Immune Response at 1 Month Post First Vaccination. — 12; 12; 12; 11 Participants
N/A N=24 Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
Cystic Fibrosis · Exocrine Pancreatic Insufficiency · Pancreatic Diseases
Primary: Number of Patients With Adverse Drug Reaction — 1 participants
Phase 2 N=136 Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Colorectal Cancer
Primary: Progression-free Survival — 5.98; 7.03; 9.20 months